Fresenius Medical Care San Antonio, Llc in Del Rio, Texas - Dialysis Center

Fresenius Medical Care San Antonio, Llc is a medicare approved dialysis facility center in Del Rio, Texas and it has 14 dialysis stations. It is located in Val Verde county at 608 N Bedell Ave, Del Rio, TX, 78840. You can reach out to the office of Fresenius Medical Care San Antonio, Llc at (830) 774-3031. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care San Antonio, Llc has the following ownership type - Profit. It was first certified by medicare in April, 1984. The medicare id for this facility is 452557 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFresenius Medical Care San Antonio, Llc
Location608 N Bedell Ave, Del Rio, Texas
No. of Dialysis Stations 14
Medicare ID452557
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


608 N Bedell Ave, Del Rio, Texas, 78840
(830) 774-3031

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Fresenius Medical Care San Antonio, Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1134662349
Organization NameFresenius Kidney Care Val Verde
Doing Business AsFresenius Medical Care San Antonio, Llc
Address608 N Bedell Ave Del Rio, Texas, 78840
Phone Number(830) 774-3031

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago


NPI Number1407840291
Doing Business AsVal Verde Renal Care Center, Inc.
Address608 N Bedell Ave Del Rio, Texas, 78840
Phone Number(830) 774-3031

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago


NPI Number1881039246
Organization NameFresenius Medical Care Val Verde Dialysis Center
Doing Business AsBio-medical Applications Of Texas, Inc.
Address608 N Bedell Ave Del Rio, Texas, 78840
Phone Number(830) 774-3031

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago


Patient Distribution

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center42
    Adult patient months included in Kt/V greater than or equal to 1.2310
    Percentage of adult patients getting regular hemodialysis at the center93
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Key regulator of fat cell development may provide a target for obesity and diabetes drugs

    New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

    Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

    An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

    New interactive resources launched to support the mental health of new mothers and fathers

    On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

    ARVO to host presentation of results from two clinical trials on neovascular AMD

    ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

    Read more Medical News

    › Verified 8 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Medical Care San Antonio, Llc with elevated calcium levels.

Patients with hypercalcemia42
Hypercalcemia patient months310
Patients with Serumphosphor43
Patients with Serumphosphor less than 3.5 mg/dL11
Patients with Serumphosphor from 3.5 to 4.5 mg/dL25
Patients with Serumphosphor from 4.6 to 5.5 mg/dL23
Patients with Serumphosphor from 5.6 to 7 mg/dL24
Patients with Serumphosphor greater than 7 mg/dL17

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 28
Patient months included in arterial venous fistula and catheter summaries 74
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment89
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer1

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary31
Hospitalization Rate in facility112 (As Expected)
Hospitalization Rate: Upper Confidence Limit267.4
Hospitalization Rate: Lower Confidence Limit50.3

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Fresenius Medical Care San Antonio, Llc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility20.9 (As Expected)
Readmission Rate: Upper Confidence Limit39.5
Readmission Rate: Lower Confidence Limit8.5

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fresenius Medical Care San Antonio, Llc get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility2 (As Expected)
SIR: Upper Confidence Limit5.44
SIR: Lower Confidence Limit.51

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Medical Care San Antonio, Llc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 25
Transfusion Rate in facility47.7 (As Expected)
Transfusion Rate: Upper Confidence Limit166.5
Transfusion Rate: Lower Confidence Limit16

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Fresenius Medical Care San Antonio, Llc lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary128
Mortality Rate in facility24.1 (As Expected)
Mortality Rate: Upper Confidence Limit37.2
Mortality Rate: Lower Confidence Limit14.7

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago


Dialysis Facility in Del Rio, TX

Fresenius Medical Care San Antonio, Llc
Location: 608 N Bedell Ave, Del Rio, Texas, 78840
Phone: (830) 774-3031
Fresenius Medical Care Of Del Rio
Location: 2201 N Bedell, Suite D, Del Rio, Texas, 78840
Phone: (830) 775-7840

News Archive

Key regulator of fat cell development may provide a target for obesity and diabetes drugs

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

New interactive resources launched to support the mental health of new mothers and fathers

On International Fathers' Mental Health Day, the Institute of Health Visiting (iHV), in partnership with Dr Ranjana Das and Dr Paul Hodkinson from the University of Surrey, is delighted to announce the launch of three new 'Factographics' interactive resources - designed to better support the mental health of new mothers and fathers.

ARVO to host presentation of results from two clinical trials on neovascular AMD

ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.

Read more Medical News

› Verified 8 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.